Close
ACHEMA MIDDLE EAST 2026

AMAL Therapeutics raises CHF 33.2 Million Series B Round

AMAL Therapeutics SA , a Swiss biotech developing peptide-based therapeutic cancer vaccines, announces that it has completed the second closing of its Series B...

Nestle China accelerates innovation

Oriented research and development of new products to lead the new trend of nutrition and health. Nestle held the “Nestle China Innovation Day” in Beijing...

Kite Announces New Worldwide Facilities and Expanded Collaboration With National Cancer Institute to Support Cell Therapy Pipeline

Kite, a Gilead Company announced it has leased a new facility in the Netherlands to engineer cell therapies in Europe. The 117,000 square-foot site...

Nasal Spray Could Lower Risk Of Opioid Addiction

The animal study tested whether using nanotechnology enables the exclusive delivery of the drug into the brain and causes analgesia (pain relief). During the...

Dr Reddy’s posts better than expected Q3 numbers but concerns remain

There were two positive developments at Dr Reddy's that were hard to miss when the company's CFO Saumen Chakraborty and COO Abhijit Mukerjee announced...

Fresenius Kabi opens extension at production plant in Mihla, eastern Germany

Fresenius Kabi opened the extension of its production plant in Mihla, Germany, today with a festive dedication ceremony attended by Mayor Rainer Laemmerhirt. The...

WuXi Biologics Initiated cGMP Manufacturing in the World’s Largest Biologics Manufacturing Facility Using Only Single-Use Bioreactors

WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company, offering end-to-end solutions for biologics discovery, development and manufacturing, today announced that its...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...